Sugi Predict

Sugi Predict / Compounds / SCHEMBL1768346

SCHEMBL1768346

SCHEMBL1768346

CN(CC(=O)O)C(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM8 O00222 2/20 0.55
▸ GRM6 O15303 2/20 0.55
▸ GRM7 Q14831 2/20 0.55
▸ GRM4 Q14833 2/20 0.55
▸ GRIN2D O15399 1/20 0.55
▸ GRIN3B O60391 1/20 0.55
▸ GSR P00390 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ GRIK1 P39086 1/20 0.55
▸ GRM5 P41594 1/20 0.55
▸ GRIA1 P42261 1/20 0.55
▸ GRIA2 P42262 1/20 0.55
▸ GRIA3 P42263 1/20 0.55
▸ SLC1A3 P43003 1/20 0.55
▸ SLC1A2 P43004 1/20 0.55
▸ SLC1A1 P43005 1/20 0.55
▸ GRIA4 P48058 1/20 0.55
▸ GRIN1 Q05586 1/20 0.55
▸ GRIN2A Q12879 1/20 0.55
▸ GRIK2 Q13002 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1768348 1.00 GRM8 (0.55) GRM8GRM6GRM7GRM4GRIN2D
SCHEMBL31105501 0.83 GLO1 (0.57) GLO1
SCHEMBL31105462 0.83 GLO1 (0.57) GLO1
SCHEMBL31105602 0.83 GLO1 (0.57) GLO1
SCHEMBL31072581 0.83 GLO1 (0.57) GLO1
SCHEMBL31105585 0.83 GLO1 (0.57) GLO1
SCHEMBL31105479 0.83 GLO1 (0.57) GLO1
SCHEMBL31072576 0.83 GLO1 (0.57) GLO1
SCHEMBL31105389 0.83 GLO1 (0.57) GLO1
SCHEMBL25355764 0.81 GRM8 (0.59) GRM8GRM6GRM7GRM4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754038-B2 Template-fixed peptidomimetics with CCR10 antagonistic activity POLYPHOR AG (CH) 2014-06-17 — — US disclosed
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY POLYPHOR AG (CH) 2012-11-08 — — US disclosed
EP-2501715-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVTY Polyphor Ag (CH) 2012-09-26 — — EP disclosed
WO-2011060937-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVTY POLYPHOR AG (CH) 2011-05-26 — — WO disclosed
WO-2011060832-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY POLYPHOR AG (CH) 2011-05-26 — — WO disclosed
US-5561133-A Thymidylate synthase inhibiting quinazolinones BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-10-01 — — US disclosed
EP-0631576-A1 DIPEPTIDYLQUINAZOLONES AS ANTI-CANCER AGENTS BTG INTERNATIONAL LIMITED (GB) 1995-01-04 — — EP disclosed
WO-1993019051-A1 DIPEPTIDYLQUINAZOLONES AS ANTI-CANCER AGENTS BRITISH TECHNOLOGY GROUP LTD (GB) 1993-09-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY CCR10, CCR1, CCRL2 GRM8 1650/4885GRM6 1857/4885GRM7 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.